MANNITOL INJECTION, USP
FRESENIUS KABI CANADA LTD
Quick answers
Is there a shortage of MANNITOL INJECTION, USP in Canada?
No. There is no current shortage of MANNITOL INJECTION, USP 25% reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MANNITOL INJECTION USP
PFIZER CANADA ULC
Other Products
MANNITOL INJ 5% ABBOVAC
ABBOTT LABORATORIES, LIMITED
MANNITOL INJ 25%
ASTRA PHARMA INC.
MANNITOL INJ 10% ABBOVAC
ABBOTT LABORATORIES, LIMITED
OSMITROL INJECTION 10%
BAXTER CORPORATION
OSMITROL INJECTION 20%
BAXTER CORPORATION
DIN
02243176
Strength
25%
Dosage Form
Solution
Route
Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from FRESENIUS KABI CANADA LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
900MG · DIN 02395150
20MG · DIN 02538644
50MG · DIN 02403536
50MG · DIN 02236926
DIN 02497697
3MG · DIN 02457482
3MG · DIN 02267659
3MG · DIN 02457474
50MG · DIN 02245248
250MG · DIN 02227029
2G · DIN 02226995
1G · DIN 02227002